Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genomic Health Inc (GHDX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genomic Health Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1131324.
Total stock buying since 2014: $2,701,600.
Total stock sales since 2014: $524,742,527.
Total stock option exercises since 2014: $54,237,607.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 37,643,330 | $0 | 4,255,395 | $302,840,723 | 1,177,273 | $31,943,202 |
| 2018 | 0 | $0 | 2,775,805 | $206,377,815 | 561,292 | $12,545,100 |
| 2017 | 0 | $0 | 218,781 | $6,847,246 | 255,541 | $4,916,282 |
| 2016 | 100,000 | $2,701,600 | 148,242 | $4,293,432 | 181,950 | $3,190,607 |
| 2015 | 0 | $0 | 65,864 | $1,910,548 | 65,864 | $879,494 |
| 2014 | 0 | $0 | 85,321 | $2,472,763 | 85,321 | $762,922 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-18 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 66.66 | 1,666,575 |
| 2018-12-17 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 67.26 | 1,681,575 |
| 2018-12-12 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 18,500 | 73.09 | 1,352,091 |
| 2018-12-11 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 57,554 | 73.35 | 4,221,528 |
| 2018-12-11 | Cole G Bradley (CFO) | Sale | 15,000 | 72.52 | 1,087,785 |
| 2018-12-11 | Cole G Bradley (CFO) | Option Ex | 15,000 | 20.08 | 301,200 |
| 2018-12-11 | Graham Ginger L (Director) | Option Ex | 24,750 | 19.25 | 476,437 |
| 2018-12-10 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 9,366 | 73.83 | 691,482 |
| 2018-12-07 | Baker/tisch Investments, Lp (Director) | Sale | 102,455 | 76.15 | 7,802,358 |
| 2018-12-06 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 74.92 | 224,766 |
| 2018-12-06 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2018-12-06 | Baker/tisch Investments, Lp (Director) | Sale | 92,679 | 75.46 | 6,993,650 |
| 2018-12-04 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 32,776 | 76.12 | 2,495,073 |
| 2018-12-03 | Baker/tisch Investments, Lp (Director) | Sale | 202,134 | 78.07 | 15,780,601 |
| 2018-12-03 | Shak Steven (Chief Scientific Officer) | Sale | 1,500 | 78.30 | 117,451 |
| 2018-12-03 | Shak Steven (Chief Scientific Officer) | Option Ex | 1,500 | 17.33 | 25,994 |
| 2018-11-30 | Baker/tisch Investments, Lp (Director) | Sale | 204,757 | 79.35 | 16,247,263 |
| 2018-11-29 | Baker/tisch Investments, Lp (Director) | Sale | 51,278 | 78.21 | 4,010,349 |
| 2018-11-28 | Baker/tisch Investments, Lp (Director) | Sale | 250,392 | 75.20 | 18,829,228 |
| 2018-11-27 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 138,610 | 74.00 | 10,257,001 |
| 2018-11-26 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 39,675 | 74.20 | 2,944,043 |
| 2018-11-16 | Baker Bros. Advisors (gp) Llc (Director) | Sale | 87,395 | 77.00 | 6,729,851 |
| 2018-11-16 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 77.11 | 1,927,740 |
| 2018-11-16 | Popovits Kimberly J (President and CEO) | Option Ex | 15,000 | 22.98 | 344,700 |
| 2018-11-15 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 76.74 | 1,918,450 |
| 2018-11-15 | Popovits Kimberly J (President and CEO) | Option Ex | 25,000 | 22.98 | 574,500 |
| 2018-11-13 | Baker Bros. Investments, L.p. (Director) | Sale | 138,712 | 79.67 | 11,051,601 |
| 2018-11-13 | Baker Bros. Investments Ii, L.p. (Director) | Sale | 114,858 | 79.76 | 9,161,533 |
| 2018-11-13 | Cole G Bradley (CFO) | Sale | 8,576 | 79.84 | 684,716 |
| 2018-11-13 | Cole G Bradley (CFO) | Option Ex | 8,576 | 20.08 | 172,206 |
| 2018-11-12 | Baker/tisch Investments, Lp (Director) | Sale | 14,415 | 80.38 | 1,158,720 |
| 2018-11-12 | Baker Bros. Investments, L.p. (Director) | Sale | 65,588 | 80.83 | 5,301,805 |
| 2018-11-09 | Baker/tisch Investments, Lp (Director) | Sale | 277,082 | 83.49 | 23,117,928 |
| 2018-11-09 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 84.26 | 463,408 |
| 2018-11-09 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-11-08 | Vaughn James J (Chief Commercial Officer) | Sale | 3,000 | 86.01 | 258,024 |
| 2018-11-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,000 | 31.12 | 93,360 |
| 2018-11-08 | Baker/tisch Investments, Lp (Director) | Sale | 76,273 | 85.80 | 6,543,842 |
| 2018-11-08 | Cohen Fred E (Director) | Sale | 10,000 | 87.36 | 873,560 |
| 2018-11-08 | Cohen Fred E (Director) | Option Ex | 10,000 | 27.75 | 277,500 |
| 2018-11-07 | Pla Frederic (COO) | Sale | 43,500 | 84.92 | 3,694,237 |
| 2018-11-07 | Pla Frederic (COO) | Option Ex | 43,500 | 27.24 | 1,184,940 |
| 2018-10-16 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 65.92 | 1,647,950 |
| 2018-10-16 | Popovits Kimberly J (President and CEO) | Option Ex | 25,000 | 22.98 | 574,500 |
| 2018-10-15 | Popovits Kimberly J (President and CEO) | Sale | 25,000 | 64.94 | 1,623,425 |
| 2018-10-15 | Popovits Kimberly J (President and CEO) | Option Ex | 25,000 | 22.98 | 574,500 |
| 2018-10-10 | Cole G Bradley (CFO) | Sale | 5,000 | 63.50 | 317,485 |
| 2018-10-10 | Cole G Bradley (CFO) | Option Ex | 5,000 | 17.18 | 85,900 |
| 2018-10-09 | Vaughn James J (Chief Commercial Officer) | Sale | 25,000 | 64.54 | 1,613,575 |
| 2018-10-09 | Vaughn James J (Chief Commercial Officer) | Option Ex | 25,000 | 28.53 | 713,325 |
| 2018-10-09 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 64.55 | 355,019 |
| 2018-10-09 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-10-08 | Vaughn James J (Chief Commercial Officer) | Sale | 25,000 | 65.77 | 1,644,250 |
| 2018-10-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 25,000 | 29.25 | 731,325 |
| 2018-10-08 | Pla Frederic (COO) | Sale | 1,500 | 65.74 | 98,607 |
| 2018-10-08 | Pla Frederic (COO) | Option Ex | 1,500 | 27.00 | 40,500 |
| 2018-09-11 | Cole G Bradley (COO) | Sale | 5,000 | 64.10 | 320,490 |
| 2018-09-11 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.18 | 85,900 |
| 2018-09-10 | Pla Frederic (Chief Bus & Prod Dev Officer) | Sale | 1,500 | 63.24 | 94,855 |
| 2018-09-10 | Pla Frederic (Chief Bus & Prod Dev Officer) | Option Ex | 1,500 | 27.00 | 40,500 |
| 2018-09-10 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 63.24 | 347,820 |
| 2018-09-10 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 27.33 | 150,315 |
| 2018-09-06 | Cohen Fred E (Director) | Sale | 8,250 | 61.51 | 507,457 |
| 2018-09-06 | Cohen Fred E (Director) | Option Ex | 8,250 | 34.44 | 284,130 |
| 2018-08-14 | Popovits Kimberly J (President and CEO) | Sale | 60,000 | 52.77 | 3,166,020 |
| 2018-08-09 | Pla Frederic (Chief Bus & Prod Dev Officer) | Sale | 5,500 | 55.96 | 307,785 |
| 2018-08-09 | Pla Frederic (Chief Bus & Prod Dev Officer) | Option Ex | 1,500 | 27.00 | 40,500 |
| 2018-08-09 | Cole G Bradley (COO) | Sale | 8,529 | 55.97 | 477,325 |
| 2018-08-09 | Cole G Bradley (COO) | Option Ex | 8,529 | 17.18 | 146,528 |
| 2018-08-09 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 55.96 | 307,802 |
| 2018-08-09 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-08-08 | Radford Jason W. (Chief Legal Officer) | Sale | 4,126 | 56.59 | 233,494 |
| 2018-08-07 | Cohen Fred E (Director) | Sale | 8,250 | 56.45 | 465,745 |
| 2018-08-07 | Cohen Fred E (Director) | Option Ex | 8,250 | 25.79 | 212,767 |
| 2018-08-06 | Graham Ginger L (Director) | Option Ex | 16,500 | 17.33 | 285,945 |
| 2018-07-16 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 53.09 | 530,890 |
| 2018-07-16 | Popovits Kimberly J (President and CEO) | Option Ex | 10,000 | 17.18 | 171,800 |
| 2018-07-09 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 49.55 | 272,552 |
| 2018-07-09 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-06-14 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 49.30 | 493,050 |
| 2018-06-14 | Popovits Kimberly J (President and CEO) | Option Ex | 10,000 | 17.18 | 171,800 |
| 2018-06-11 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 50.56 | 278,063 |
| 2018-06-11 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-06-04 | Vaughn James J (Chief Commercial Officer) | Sale | 93,414 | 45.61 | 4,260,892 |
| 2018-06-04 | Vaughn James J (Chief Commercial Officer) | Option Ex | 80,768 | 25.34 | 2,046,499 |
| 2018-05-14 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 38.09 | 380,880 |
| 2018-05-14 | Popovits Kimberly J (President and CEO) | Option Ex | 10,000 | 17.18 | 171,800 |
| 2018-05-09 | Shak Steven (Chief Scientific Officer) | Sale | 5,500 | 36.68 | 201,745 |
| 2018-05-09 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,500 | 17.33 | 95,314 |
| 2018-05-02 | Vaughn James J (Chief Commercial Officer) | Sale | 1,497 | 32.50 | 48,652 |
| 2018-04-16 | Popovits Kimberly J (President and CEO) | Sale | 15,000 | 33.19 | 497,880 |
| 2018-04-16 | Popovits Kimberly J (President and CEO) | Option Ex | 15,000 | 17.18 | 257,700 |
| 2018-03-14 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 32.01 | 160,050 |
| 2018-03-14 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 17.18 | 85,900 |
| 2018-03-13 | Cole G Bradley (COO) | Sale | 5,000 | 33.12 | 165,585 |
| 2018-03-13 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2018-03-09 | Baker/tisch Investments, Lp (Director) | Option Ex | 49,500 | 18.50 | 915,750 |
| 2018-02-20 | Febbo Phillip G. (Chief Medical Officer) | Sale | 4,942 | 33.08 | 163,471 |
| 2018-02-20 | Leber Laura (Chief Communication Officer) | Sale | 3,374 | 33.14 | 111,804 |
| 2018-02-20 | Cole G Bradley (COO) | Sale | 5,000 | 33.12 | 165,615 |
| 2018-02-20 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2018-02-14 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 32.93 | 329,340 |
| 2018-02-14 | Popovits Kimberly J (President and CEO) | Option Ex | 10,000 | 17.18 | 171,800 |
| 2018-01-16 | Popovits Kimberly J (President and CEO) | Sale | 10,000 | 35.34 | 353,370 |
| 2018-01-16 | Popovits Kimberly J (President and CEO) | Option Ex | 10,000 | 17.18 | 171,800 |
| 2018-01-09 | Cole G Bradley (COO) | Sale | 5,000 | 35.51 | 177,565 |
| 2018-01-09 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2018-01-02 | Vaughn James J (Chief Commercial Officer) | Sale | 3,004 | 34.09 | 102,406 |
| 2018-01-02 | Vaughn James J (Chief Commercial Officer) | Option Ex | 2,169 | 17.33 | 37,588 |
| 2017-12-19 | Febbo Phillip G. (Chief Medical Officer) | Sale | 5,334 | 36.91 | 196,877 |
| 2017-12-19 | Febbo Phillip G. (Chief Medical Officer) | Option Ex | 5,000 | 27.00 | 135,000 |
| 2017-12-15 | Leber Laura (Chief Communication Officer) | Sale | 9,000 | 35.00 | 315,000 |
| 2017-12-15 | Leber Laura (Chief Communication Officer) | Option Ex | 9,000 | 17.33 | 155,969 |
| 2017-12-14 | Leber Laura (Chief Communication Officer) | Sale | 12,000 | 32.00 | 384,000 |
| 2017-12-14 | Leber Laura (Chief Communication Officer) | Option Ex | 12,000 | 21.52 | 258,240 |
| 2017-12-14 | Popovits Kimberly J (President and CEO) | Sale | 20,000 | 31.50 | 630,000 |
| 2017-12-14 | Popovits Kimberly J (President and CEO) | Option Ex | 20,000 | 17.25 | 345,100 |
| 2017-12-12 | Cole G Bradley (COO) | Sale | 5,000 | 29.94 | 149,710 |
| 2017-12-12 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-11-07 | Cole G Bradley (COO) | Sale | 5,000 | 31.47 | 157,330 |
| 2017-11-07 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-11-02 | Vaughn James J (Chief Commercial Officer) | Sale | 1,379 | 32.51 | 44,824 |
| 2017-11-02 | Vaughn James J (Chief Commercial Officer) | Option Ex | 924 | 17.33 | 16,012 |
| 2017-11-01 | Vaughn James J (Chief Commercial Officer) | Sale | 5,617 | 32.58 | 183,007 |
| 2017-11-01 | Vaughn James J (Chief Commercial Officer) | Option Ex | 3,907 | 17.33 | 67,708 |
| 2017-10-10 | Cole G Bradley (COO) | Sale | 5,000 | 31.93 | 159,635 |
| 2017-10-10 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-09-14 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 31.00 | 154,990 |
| 2017-09-14 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-09-12 | Cole G Bradley (COO) | Sale | 5,000 | 31.86 | 159,290 |
| 2017-09-12 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-08-14 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 30.22 | 151,110 |
| 2017-08-14 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-08-08 | Vaughn James J (Chief Commercial Officer) | Sale | 8,000 | 30.59 | 244,728 |
| 2017-08-08 | Vaughn James J (Chief Commercial Officer) | Option Ex | 6,500 | 23.31 | 151,515 |
| 2017-08-08 | Cole G Bradley (COO) | Sale | 5,000 | 30.57 | 152,845 |
| 2017-08-08 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-07-19 | Febbo Phillip G. (Chief Medical Officer) | Sale | 3,174 | 33.57 | 106,544 |
| 2017-07-11 | Cole G Bradley (COO) | Sale | 5,000 | 32.83 | 164,135 |
| 2017-07-11 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-07-05 | Popovits Kimberly J (President and CEO) | Sale | 1,468 | 32.66 | 47,952 |
| 2017-07-05 | Popovits Kimberly J (President and CEO) | Option Ex | 1,468 | 17.33 | 25,440 |
| 2017-07-03 | Popovits Kimberly J (President and CEO) | Sale | 3,532 | 32.56 | 114,987 |
| 2017-07-03 | Popovits Kimberly J (President and CEO) | Option Ex | 3,532 | 17.33 | 61,209 |
| 2017-06-23 | Shak Steven (Chief Scientific Officer) | Sale | 5,000 | 33.27 | 166,370 |
| 2017-06-23 | Shak Steven (Chief Scientific Officer) | Option Ex | 5,000 | 23.31 | 116,550 |
| 2017-06-13 | Cole G Bradley (COO) | Sale | 5,000 | 31.67 | 158,340 |
| 2017-06-13 | Cole G Bradley (COO) | Option Ex | 5,000 | 17.33 | 86,649 |
| 2017-06-05 | Popovits Kimberly J (President and CEO) | Sale | 5,000 | 32.32 | 161,580 |
| 2017-06-05 | Popovits Kimberly J (President and CEO) | Option Ex | 5,000 | 17.33 | 86,649 |
Insider trading activities including stock purchases, stock sales, and option exercises of GHDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genomic Health Inc (symbol GHDX, CIK number 1131324) see the Securities and Exchange Commission (SEC) website.